THE MIZEUR GROUP, LLC

Lobbying for CLENE NANOMEDICINE · Biopharmaceutical company treating neurodegenerative diseases.

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Maryland · House · Senate · $5,000.00 income · posted May 20, 2025

Lobbying activity 1

Health Issues

Ongoing discussions about regulatory flexibility for accelerated approval of rare disease drugs for neurodegenerative conditions.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.